Biocartis Group announces development of SARS-CoV-2 test The SARS-CoV-2 test is targeted to help healthcare providers manage COVID-19 pandemic through rapid, easy testing of individuals…
Biocartis Group partners with Immunexpress For co-commercialisation agreement for SeptiCyte RAPID Test for use on Biocartis’ fully automated molecular diagnostics platform…
